Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis
Carmen Criscitiello(University of Milan), Giuseppe Curigliano(European Institute of Oncology), Stephanie M. Wong(Brigham and Women's Hospital), Michele Santangelo(University of Naples Federico II), Giulia Viale(Istituti di Ricovero e Cura a Carattere Scientifico), William T. Barry(Harvard University), Mehra Golshan(Yale New Haven Hospital)
Cited by 50
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k